Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – Here’s What Happened

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY)’s stock price gapped up prior to trading on Tuesday. The stock had previously closed at $11.00, but opened at $12.10. Ambu A/S shares last traded at $12.10, with a volume of 438 shares trading hands.

Analysts Set New Price Targets

Separately, UBS Group cut Ambu A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. One equities research analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Ambu A/S Stock Up 4.0%

The company has a current ratio of 2.77, a quick ratio of 1.69 and a debt-to-equity ratio of 0.08. The stock has a 50-day moving average of $11.00 and a 200-day moving average of $11.00. The firm has a market cap of $2.84 billion, a price-to-earnings ratio of 40.33 and a beta of 0.93.

Ambu A/S (OTCMKTS:AMBBY) last released its quarterly earnings results on Tuesday, August 25th. The company reported $0.09 EPS for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.49%. The company had revenue of $255.12 million for the quarter.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.